SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia

• Sibylle C. Mellinghoff,
• Leonie Mayer,
• Sandra Robrecht,
• Leonie M. Weskamm,
• Christine Dahlke,
• Henning Gruell,
• Maike Schlotz,
• Kanika Vanshylla,
• Hans A. Schloser,
• Martin Thelen,
• Anna-Maria Fink,
• Kirsten Fischer,
• Florian Klein,
• Marylyn M. Addo,
• Barbara Eichhorst,
• Michael Hallek,
• Petra Langerbeins

Affiliations

Sibylle C. Mellinghoff

Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne, Germany; German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg

Leonie Mayer

Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner Site Hamburg-Lubeck-Borstel-Riems, Hamburg

Sandra Robrecht

Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne

Leonie M. Weskamm

Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner Site Hamburg-Lubeck-Borstel-Riems, Hamburg

Christine Dahlke

Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner Site Hamburg-Lubeck-Borstel-Riems, Hamburg

Henning Gruell

Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne

Maike Schlotz

Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne

Kanika Vanshylla

Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne

Hans A. Schloser

Centre for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne

Martin Thelen

Centre for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne

Anna-Maria Fink

Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne

Kirsten Fischer

Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne

Florian Klein

German Centre for Infection Research (DZIF), partner site Bonn-Cologne, Cologne, Germany; Institute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; Centre for Molecular Medicine Cologne, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne

Marylyn M. Addo

Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; Division of Infectious Diseases, First Department of Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; German Centre for Infection Research (DZIF), Partner Site Hamburg-Lubeck-Borstel-Riems, Hamburg

Barbara Eichhorst

Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne

Michael Hallek

Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne

Petra Langerbeins

Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Centre for Integrated Oncology Aachen Bonn Cologne Dusseldorf (CIO ABCD), University of Cologne, Cologne